CompletedNot Applicable

Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders

United Arab Emirates72 participantsStarted 2019-02-25

Plain-language summary

This study wants to evaluate significant clinical impact of different AMH isoforms in serum can be present or absent in expected poor responder participants. The specific AMH isoforms could therefore be measured in expected poor responder participants in order to obtain a more realistic clinical picture and therefore be able to give proper information to the participants and selection of medication dose for ovarian stimulation.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pre-treatment AMH recording below 1.1 ng/ml on day 2 or 3 of the menstrual cycle. * BMI between 18 and 30 kg/m2. Exclusion Criteria: * Pregnancy. * Breastfeeding. * Intake of oral contraceptive pills or steroids for the last two menstrual cycles. * Endometriosis. * Previous surgical intervention, which could have an impact on the ovarian reserve, e.g. ovarian cyst removal, removal of one or both tubes, tubal ligation for sterilisation

What they're measuring

AMH serum levels

Timeframe: 1 day

Trial details

NCT IDNCT03826888

SponsorART Fertility Clinics LLC

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-23

View on ClinicalTrials.gov More Anti-Mullerian Hormone Isoforms trials